Drugs / Combined tetanus, reduced diphtheria and acellular pertussis vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00329901 | Apr 2006 → May 2007 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Combined tetanus, reduced diphtheria and acellular pertussis vaccine | “Biological: Combined tetanus, reduced diphtheria and acellular pertussis vaccine (Tdap)” NCT00329901 ↗ |
| Known as | Tdap | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00329901 ↗ |
| Modality | Vaccine | “a combined tetanus, reduced diphtheria, and acellular pertussis vaccine” PMID 20164251 ↗ Feb 2010 |